BRAVE Act of 2025

1) WHAT HAPPENED: On November 12, 2025, Rep. Crow (D-CO) introduced H.R. 6024, the BRAVE Act of 2025, referred to the House Committees on Veterans' Affairs and Armed Services. On December 3, 2025, it was referred to the Subcommittee on Health. As of today, April 29, 2026, the bill remains in early committee stage with no further floor action. An identical companion bill, S609, was referred to the Senate Veterans' Affairs Committee. 2) THE MONEY TRAIL: The bill authorizes policy changes — waiving licensure requirements for VA mental health counselors, extending the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program (increasing the maximum annual grant amount), and requiring studies and reports. It does not appropriate new funding. Authorization bills set policy ceilings; actual money requires a separate appropriations act. The grant program extension expands eligibility for community-based non-profit organizations, not for-profit hospital chains. 3) STRUCTURAL ANALYSIS: For hospital operators ($HCA, $UHS), the bill creates no new payer demand. VA community care purchasing (the Veterans Choice program) is governed by separate appropriations and the MISSION Act, which this bill does not amend. The Executive Order on April 18, 2026 accelerating psychedelic therapies is structurally positive for $CMPS, $MNMD, $GHRS, $ATAI, $CYBN, $NUMI, $PSYC, $DRUG — but it is a standalone presidential action on FDA regulatory pathways, not linked to VA funding in this bill. 4) MARKET DATA CONTEXT: $HCA at $431.92 has fallen 8.36% in 7 days and 8.46% in 30 days; $UHS at $162.54 has fallen 10.06% in 7 days and 11.68% in 30 days. These declines are driven by broader sector headwinds, not legislative activity on this early-stage bill. The bill's zero-funding structure provides no catalyst to reverse these trends. 5) TIMELINE: The bill requires subcommittee mark-up, full committee passage, House floor vote, Senate companion passage (S609), conference committee if differences exist, and then — critically — a separate appropriations bill. This is a multi-year path at best. Probability of enacted law with funding in this Congress is low given the early stage and lack of committee leadership sponsorship.